SPONTANEOUSLY REMITTING DISEASE

被引：0
|
作者：
GROUND, M
机构：
来源：
MEDICAL JOURNAL OF AUSTRALIA | 1993年 / 158卷 / 01期
关键词：
D O I：
10.5694/j.1326-5377.1993.tb121677.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：69 / 69
页数：1
相关论文
共 50 条
  • [41] Predictors of Disease Activity and Worsening in Relapsing-Remitting Multiple Sclerosis
    Zhang, Yinan
    Cofield, Stacey
    Cutter, Gary
    Krieger, Stephen
    Wolinsky, Jerry S.
    Lublin, Fred
    NEUROLOGY-CLINICAL PRACTICE, 2022, 12 (04) : E58 - E65
  • [42] PREVALENCE OF SPONTANEOUSLY OCCURRING CARDIOVASCULAR-DISEASE IN DOGS
    DETWEILER, K
    BOTTS, RP
    HUBBEN, K
    PATTERSON, DF
    AMERICAN JOURNAL OF PUBLIC HEALTH AND THE NATIONS HEALTH, 1961, 51 (02): : 228 - &
  • [43] SPONTANEOUSLY OCCURRING PARKINSONS-DISEASE IN A NONHUMAN PRIMATE
    MOSS, MB
    SAINTHILAIRE, M
    FELDMAN, RG
    VALERI, CR
    MAJORTHERAN, C
    DURSO, R
    ANNALS OF NEUROLOGY, 1991, 30 (02) : 297 - 297
  • [44] Disease-modifying therapies in relapsing-remitting multiple sclerosis
    Gonzalez-Andrade, Fabricio
    Luis Alcaraz-Alvarez, Jose
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2010, 6 : 365 - 373
  • [45] Cerebrovascular reactivity and disease activity in relapsing-remitting multiple sclerosis
    Smolinski, Lukasz
    Litwin, Tomasz
    Kruk, Karolina
    Skowronska, Marta
    Kurkowska-Jastrzebska, Iwona
    Czlonkowska, Anna
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 29 (02): : 183 - 188
  • [46] Disease reactivation after cessation of disease-modifying therapy in relapsing-remitting multiple sclerosis
    Roos, I.
    Malpas, C.
    Leray, E.
    Casey, R.
    Horakova, D.
    Havrdova, E. Kubala
    Debouverie, M.
    Patti, F.
    De Seze, J.
    Izquierdo, G.
    Eichau, S.
    Edan, G.
    Prat, A.
    Girard, M.
    Ozakbas, S.
    Grammond, P.
    Zephir, H.
    Ciron, J.
    Maillart, E.
    Moreau, T.
    Amato, M. P.
    Labauge, P.
    Alroughani, R.
    Buzzard, K.
    Skibina, O.
    Terzi, M.
    Laplaud, D.
    Berger, E.
    Grand'Maison, F.
    Lebrun-Frenay, C.
    Cartechini, E.
    Boz, C.
    Lechner-Scott, J.
    Clavelou, P.
    Stankoff, B.
    Prevost, J.
    Kappos, L.
    Pelletier, J.
    Shaygannejad, V.
    Yamout, B.
    Gerlach, O.
    Spitaleri, D.
    van Pesch, V.
    Gout, O.
    Turkoglu, R.
    Heinzlef, O.
    Thouvenot, E.
    Vukusic, S.
    Butzkueven, H.
    Kalincik, T.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 673 - 676
  • [47] Sustained disease remission after discontinuation of disease modifying treatments in relapsing-remitting multiple sclerosis
    Pasca, Matteo
    Forci, Benedetta
    Mariottini, Alice
    Mechi, Claudia
    Barilaro, Alessandro
    Massacesi, Luca
    Repice, Anna Maria
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 47
  • [48] Disease reactivation after cessation of disease-modifying therapy in relapsing-remitting multiple sclerosis
    Roos, I.
    Malpas, C. B.
    Leray, E.
    Buzzard, K.
    Skibina, O.
    Lechner-Scott, J.
    McCombe, P.
    Slee, M.
    Butler, E.
    Macdonell, R.
    van der Walt, A.
    Hodgkinson, S.
    Barnett, M.
    Vucic, S.
    Vukusic, S.
    Butzkueven, H.
    Kalincik, T.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 : 6 - 7
  • [49] Therapy-Resistant, Spontaneously Remitting Generalized Neutrophilic Eccrine Hidradenitis in a Healthy Patient Decreases the Expression of Dermcidin in Affected Eccrine Glands
    Kambayashi, Yumi
    Fujimura, Taku
    Yamasaki, Kenshi
    Aiba, Setsuya
    CASE REPORTS IN DERMATOLOGY, 2011, 3 (03): : 228 - 234
  • [50] Established disease-modifying treatments in relapsing-remitting multiple sclerosis
    Oh, Jiwon
    O'Connor, Paul W.
    CURRENT OPINION IN NEUROLOGY, 2015, 28 (03) : 220 - 229
12345